e-cigarette
Use of Electronic Cigarettes Among Cannabis-Naive Adolescents and Its Association With Future Cannabis Use
Cardiovascular functions and arterial stiffness after JUUL use
Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019
Cardiorespiratory and Immunologic Effects of Electronic Cigarettes
CNPT Consensus Document on Nicotine Delivery Devices

Association between E-Cigarette Use and Depression in the Behavioral Risk Factor Surveillance System, 2016-2017
Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019
Eliminating Youth Electronic Cigarette Use: The Role for Drug Therapies Public Hearing
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing to discuss the effort to eliminate youth electronic cigarette (e-cigarette) use as well as other tobacco product use, with a focus on the potential role of drug therapies to support cessation and the issues impacting the development of such therapies.
Date and Location
December 5, 2018
The meeting will be held at: